公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
---|---|---|---|---|---|---|
2018 | Addition of one session with a specialist counselor did not increase efficacy of a family physician-led smoking cessation program | Chung Y.-H.; HAO-HSIANG CHANG ; CHIA-WEN LU ; KUO-CHIN HUANG ; FEI-RAN GUO | Journal of International Medical Research | 2 | 2 | |
2014 | Continuation of statin therapy and a decreased risk of atrial fibrillation/flutter in patients with and without chronic kidney disease | CHIA-HSUIN CHANG ; Lee Y.-C.; CHIA-TI TSAI ; SHENG-NAN CHANG ; Chung Y.-H.; Lin M.-S.; JOU-WEI LIN ; Lai M.-S. | Atherosclerosis | 112 | 111 | |
2016 | Design and Control of Reactive Distillation Process for the Production of Methyl Valerate | Chen C.-L. ; Chung Y.-H.; Lee H.-Y. | Industrial and Engineering Chemistry Research | 21 | 20 | |
2019 | Perturbational Gene-Expression Signatures for Combinatorial Drug Discovery | Huang C.-T.; Hsieh C.-H.; Chung Y.-H.; Oyang Y.-J. ; Huang H.-C.; Hsueh-Fen Juan | iScience | |||
2012 | Self-encapsulated doping of n-type graphene transistors with extended air stability | Ho P.-H.; Yeh Y.-C.; Wang D.-Y.; Li S.-S.; Chen H.-A.; Chung Y.-H.; Lin C.-C.; Wang W.-H.; Chen C.-W.; CHUN-WEI CHEN | ACS Nano | |||
2013 | Statins of high versus low cholesterol-lowering efficacy and the development of severe renal failure | Chung Y.-H.; Lee Y.-C.; CHIA-HSUIN CHANG ; Lin M.-S.; JOU-WEI LIN ; Lai M.-S. | Pharmacoepidemiology and Drug Safety | 30 | 28 | |
2015 | Wavelength-selective dual p- and n-type carrier transport of an organic/graphene/inorganic heterostructure | Ho P.-H.; Li S.-S.; Liou Y.-T.; Wen C.-Y.; Chung Y.-H.; CHUN-WEI CHEN ; CHENG-YEN WEN | Advanced Materials | 25 | 23 |